Novakand Pharma AB (KAN.ST) Q3 2024 Earnings

23AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.12
-0.11
-0.11
-0.11

Details

Expected EPS
-0.111019835859669
Actual EPS
N/A
Surprise EPS
0.11
Surprise Percent
+100%

Description

Novakand Pharma AB (KAN.ST) will report earnings of for Q3 2024 on August 23, 2024.

0 Comments

Share your thoughts